MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review
- PMID: 35751930
- PMCID: PMC9221922
- DOI: 10.1016/j.jiph.2022.06.012
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review
Abstract
Background: As the therapeutic regimens against the COVID-19 remain scarce, the microRNAs (miRNAs) can be exploited to generate efficient therapeutic targets. The miRNAs have been found to play pivotal roles in the several regulatory functions influencing the prognosis of viral infection. The miRNAs have a prospective role in the up and down regulation of the ACE2 receptors. This review examines the clinical applications, as well as the possible threats associated with the use of miRNAs to combat the deleterious consequences of SARS-CoV-2 infection.
Methodology: This article was compiled to evaluate how the miRNAs are involved in the SARS-CoV-2 pathogenesis and infection, and their potential functions which could help in the development of therapeutic targets against the COVID-19. The sources of the collected information include the several journals, databases and scientific search engines such as the Google scholar, Pubmed, Science direct, official website of WHO, among the other sites. The investigations on the online platform were conducted using the keywords miRNA biogenesis, miRNA and ACE2 interaction, therapeutic role of miRNAs against SARS-CoV-2 and miRNA therapy side effects.
Results: This review has highlighted that the miRNAs can be exploited to generate potential therapeutic targets against the COVID-19. Changes in the miRNA levels following viral replication are an essential component of the host response to infection. The collection and modification of miRNA modulates may help to minimize the deleterious consequences of SARS-CoV-2 infection, such as by controlling or inhibiting the generation of cytokines and chemokines. The degradation of viral RNA by the cellular miRNAs, along with the reduced expression of ACE2 receptors, can substantially reduce the viral load. Specific miRNAs have been found to have an antiviral influence, allowing the immune system to combat the infection or forcing the virus into a latency stage.
Conclusion: This review summarizes several studies revealing the involvement of miRNAs in diverse and complex processes during the infection process of SARS-CoV-2. The miRNAs can substantially reduce the viral load by degradation of viral RNA and reduced expression of ACE2 receptors, besides mitigating the deleterious consequences of the exaggerated secretion of cytokines. Extensive investigations need to be done by the scientific community to utilize the miRNA based strategies for the development of effective therapeutic targets against the COVID-19.
Keywords: ACE2 receptor; COVID-19; MiRNA; SARS-CoV-2; Therapeutics.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest All authors report no conflicts of interest relevant to this article.
Figures




Similar articles
-
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1. Infect Genet Evol. 2021. PMID: 33812037 Free PMC article.
-
Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.Genes (Basel). 2020 Nov 16;11(11):1354. doi: 10.3390/genes11111354. Genes (Basel). 2020. PMID: 33207533 Free PMC article.
-
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.Drugs. 2021 Apr;81(5):517-531. doi: 10.1007/s40265-021-01474-5. Epub 2021 Feb 27. Drugs. 2021. PMID: 33638807 Free PMC article. Review.
-
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?Infect Genet Evol. 2020 Nov;85:104417. doi: 10.1016/j.meegid.2020.104417. Epub 2020 Jun 8. Infect Genet Evol. 2020. PMID: 32526370 Free PMC article.
-
Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review.Rev Med Virol. 2022 Jul;32(4):e2321. doi: 10.1002/rmv.2321. Epub 2021 Dec 27. Rev Med Virol. 2022. PMID: 34958163 Review.
Cited by
-
Impact of COVID-19 Pandemic on Routine Childhood Immunization Programs in Indonesia: Taking Rural and Urban Area into Account.Patient Prefer Adherence. 2024 Mar 13;18:667-675. doi: 10.2147/PPA.S448901. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 38505189 Free PMC article.
-
Clinical outcomes following hospitalization for COVID-19 in patients with cardiac sarcoidosis in the United States: a propensity-matched analysis from national inpatient sample database from April 2020 to December 2021.Ann Med Surg (Lond). 2024 Aug 22;86(10):5696-5703. doi: 10.1097/MS9.0000000000002474. eCollection 2024 Oct. Ann Med Surg (Lond). 2024. PMID: 39359767 Free PMC article.
-
In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs.Front Cell Infect Microbiol. 2022 Nov 28;12:966870. doi: 10.3389/fcimb.2022.966870. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36519126 Free PMC article.
-
miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome.Diagnostics (Basel). 2023 Mar 14;13(6):1091. doi: 10.3390/diagnostics13061091. Diagnostics (Basel). 2023. PMID: 36980399 Free PMC article. Review.
-
Decoding the intricacies: a comprehensive analysis of microRNAs in the pathogenesis, diagnosis, prognosis and therapeutic strategies for COVID-19.Front Med (Lausanne). 2024 Oct 7;11:1430974. doi: 10.3389/fmed.2024.1430974. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39434774 Free PMC article. Review.
References
-
- Maulud S.Q., Majed S.O., Ali B.A., Jalal P.J., Azeez S.H., Mohammad K.A. Epidemiological approach of SARS-CoV2 in the first month of appearance in the Kurdistan Region of Iraq. Eur J Mol Clin Med. 2020;7:2853–2865.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous